Henipavirus: Ecology, Molecular Virology, and PathogenesisLEE, Benhur; ROTA, Paul A.Current Topics in Microbiology and Immunology. 2012, Vol 359, issn 0070-217X, 234 p.Serial Issue

Molecular Virology of the HenipavirusesLO, Michael K; ROTA, Paul A.Current Topics in Microbiology and Immunology. 2012, Vol 359, pp 41-58, issn 0070-217X, 18 p.Article

Nipah and Hendra Virus Interactions with the Innate Immune SystemBASLER, Christopher F.Current Topics in Microbiology and Immunology. 2012, Vol 359, pp 123-152, issn 0070-217X, 30 p.Article

Diagnosis of Henipavirus Infection: Current Capabilities and Future DirectionsWANG, Lin-Fa; DANIELS, Peter.Current Topics in Microbiology and Immunology. 2012, Vol 359, pp 179-196, issn 0070-217X, 18 p.Article

Identification of individual genotypes of measles virus using surface enhanced Raman spectroscopyHOANG, Vinh; TRIPP, Ralph A; ROTA, Paul et al.Analyst (London. 1877. Print). 2010, Vol 135, Num 12, pp 3103-3109, issn 0003-2654, 7 p.Conference Paper

Global Progress Toward Measles Eradication and Prevention of Rubella and Congenital Rubella SyndromeCOCHI, Stephen L; STREBEL, Peter; HOEKSTRA, Edward et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, 575 p., SUP1Serial Issue

The Cost-Effectiveness of Supplementary Immunization Activities for Measles: A Stochastic Model for UgandaBISHAI, David; JOHNS, Benjamin; NAIR, Divya et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S107-S115, SUP1Article

Who Gets Measles in Europe?MUSCAT, Mark.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S353-S365, SUP1Article

Status of Rubella and Congenital Rubella Syndrome Surveillance, 2005-2009, the World Health Organization European RegionZIMMERMAN, Laura A; MUSCAT, Mark; JANKOVIC, Dragan et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S381-S388, SUP1Article

Progress Toward Measles Elimination in the People's Republic of China, 2000-2009CHAO MA; ZHIJIE AN; WEIZHONG YANG et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S447-S454, SUP1Article

Epidemiology of a Measles Epidemic in Vietnam 2008-2010SNIADACK, David H; MENDOZA-ALDANA, Jorge; DANG THI THANH HUYEN et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S476-S482, SUP1Article

Dried Blood Spots on Filter Paper as an Alternative Specimen for Measles Diagnostics: Detection of Measles Immunoglobulin M Antibody by a Commercial Enzyme ImmunoassayUZICANIN, Amra; LUBEGA, Irene; NANUYNJA, Miriam et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S564-S569, SUP1Article

Long-term neurological and functional outcome in nipah virus infectionSEJVAR, James J; HOSSAIN, Jahangir; UDDIN, Rafique et al.Annals of neurology. 2007, Vol 62, Num 3, pp 235-242, issn 0364-5134, 8 p.Article

Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston- Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in MalawiFOWLKES, Ashley; WITTE, Desiree; CUTTS, Felicity et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S149-S157, SUP1Article

Measles Mortality Reduction and Pre- Elimination in the African Region, 2001-2009MASRESHA, Balcha G; FALL, Amadou; ESHETU, Messeret et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S198-S204, SUP1Article

Preplanned National Measles Vaccination Campaign at the Beginning of a Measles Outbreak-Sierra Leone, 2009-2010SUGERMAN, David E; FALL, Amadou; GUIGUI, Marie-Thérèse et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S260-S269, SUP1Article

What Will It Take to Achieve Measles Elimination in the World Health Organization European Region: Progress From 2003-2009 and Essential Accelerated ActionsMARTIN, Rebecca; WASSILAK, Steven; EMIROGLU, Nedret et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S325-S334, SUP1Article

Closer to the Goal: Efforts in Measles Elimination in Germany 2010SIEDLER, Anette; MANKERTZ, Annette; REITER, Sabine et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S373-S380, SUP1Article

Progress and Challenges for Measles Elimination by 2012 in the Western Pacific RegionSNIADACK, David H; MENDOZA-ALDANA, Jorge; JEE, Youngmee et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S439-S446, SUP1Article

Laboratory Characterization of Measles Virus Infection in Previously Vaccinated and Unvaccinated IndividualsHICKMAN, Carole J; HYDE, Terri B; TAMIN, Azaibi et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S549-S558, SUP1Article

Prior DNA vaccination does not interfere with the live-attenuated measles vaccinePREMENKO-LANIER, Mary; ROTA, Paul; RHODES, Gary et al.Vaccine. 2004, Vol 22, Num 5-6, pp 762-765, issn 0264-410X, 4 p.Article

Progress Toward Control of Rubella and Prevention of Congenital Rubella Syndrome-Worldwide, 2009REEF, S. E; STREBEL, P; DABBAGH, A et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S24-S27, SUP1Article

Risk Analysis for Measles Reintroduction After Global Certification of EradicationSANDERS, Raymond; DABBAGH, Alya; FEATHERSTONE, David et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S71-S77, SUP1Article

Assessing the Cost-Effectiveness of Measles Elimination in Uganda: Local Impact of a Global Eradication ProgramBABIGUMIRA, Joseph B; LEVIN, Ann; BURGESS, Colleen et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S116-S123, SUP1Article

Using Cost-Effectiveness Analysis to Support Research and Development Portfolio Prioritization for Product Innovations in Measles VaccinationGARRISON, Louis P; BAUCH, Chris T; BRESNAHAN, Brian W et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S124-S132, SUP1Article